MARIA MOTTA: Open Payments
NPI 1649819350 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$21,118 in 61 payments from 14 companies in 2025. Trend: 2023 $1,072 · 2024 $464 · 2025 $21,118
Speaker / faculty: $9,643Travel & lodging: $6,070Consulting: $2,880Food & beverage: $1,771Speaker / faculty: $679Education: $75
| Company | Payments | Amount |
|---|---|---|
| Syndax Pharmaceuticals, Inc. | 27 | $13,214 |
| Amgen Inc. | 9 | $6,154 |
| AstraZeneca Pharmaceuticals LP | 7 | $679 |
| TAIHO ONCOLOGY, INC. | 4 | $425 |
| Stemline Therapeutics Inc. | 2 | $197 |
| Incyte Corporation | 2 | $147 |
| Astellas Pharma US Inc | 1 | $75 |
| Daiichi Sankyo Inc. | 3 | $66 |
| JAZZ PHARMACEUTICALS INC. | 1 | $39 |
| Celgene Corporation | 1 | $30 |
Products named: REVUFORJ, BLINCYTO, ELZONRIS, Niktimvo, Vanflyta, CALQUENCE, RYLAZE, REBLOZYL.
Industry payments across CA — which companies pay providers there.
